World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
116
Citations
53258
World Ranking
375
National Ranking
236

Medicine

D-Index
117
Citations
53700
World Ranking
4195
National Ranking
2298

Overview

Jeffrey N. Martin is affiliated with the University of California, San Francisco in the United States. Their work primarily focuses on medicine, with a substantial emphasis on infectious diseases, neurology, oncology, virology, and immunology.

The scientist's research covers various key topics such as:

  • Long-Term Effects of COVID-19
  • HIV/AIDS Research and Interventions
  • COVID-19 Clinical Research Studies
  • HIV Research and Treatment
  • SARS-CoV-2 and COVID-19 Research
  • Viral-associated cancers and disorders
  • HIV/AIDS drug development and treatment

Jeffrey N. Martin has contributed to several recent papers, including:

  • Tutorial on directed acyclic graphs, 2021, Journal of Clinical Epidemiology
  • Markers of Immune Activation and Inflammation in Individuals With Postacute Sequelae of Severe Acute Respiratory Syndrome Coronavirus 2 Infection, 2021, The Journal of Infectious Diseases
  • Long COVID manifests with T cell dysregulation, inflammation and an uncoordinated adaptive immune response to SARS-CoV-2, 2024, Nature Immunology
  • Long-term SARS-CoV-2-specific immune and inflammatory responses in individuals recovering from COVID-19 with and without post-acute symptoms, 2021, Cell Reports
  • Differential decay of intact and defective proviral DNA in HIV-1-infected individuals on suppressive antiretroviral therapy, 2020, JCI Insight

Frequent coauthors with whom Jeffrey N. Martin has collaborated include:

  • Steven G. Deeks
  • Michael J. Peluso
  • J. Daniel Kelly
  • Timothy J. Henrich
  • Rebecca Hoh

The scientist's work has been published repeatedly in venues such as:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • UNC Libraries
  • The Journal of Infectious Diseases
  • Open Forum Infectious Diseases
  • JCI Insight

Best Publications

  • Microbial translocation is a cause of systemic immune activation in chronic HIV infection

    Jason M. Brenchley;David A. Price;Timothy W. Schacker;Tedi E. Asher

  • The major genetic determinants of HIV-1 control affect HLA class I peptide presentation

    Pereyra F;Jia X;McLaren Pj

  • Closing the gap: increases in life expectancy among treated HIV-positive individuals in the United States and Canada.

    Hasina Samji;Angela Cescon;Robert S. Hogg;Robert S. Hogg;Sharada P. Modur

  • Effect of early versus deferred antiretroviral therapy for HIV on survival.

    Mari M. Kitahata;Stephen J. Gange;Alison G. Abraham;Barry Merriman

  • Immune activation set point during early HIV infection predicts subsequent CD4+ T-cell changes independent of viral load.

    Steven G. Deeks;Christina M. R. Kitchen;Lea Liu;Hua Guo

  • Sexual Transmission and the Natural History of Human Herpesvirus 8 Infection

    Jeffrey N. Martin;Donald E. Ganem;Dennis H. Osmond;Kimberly A. Page-Shafer

  • Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1

    Maureen P. Martin;Ying Qi;Xiaojiang Gao;Eriko Yamada

  • T Cell Activation Is Associated with Lower CD4+ T Cell Gains in Human Immunodeficiency Virus-Infected Patients with Sustained Viral Suppression during Antiretroviral Therapy

    Peter W Hunt;Jeffrey N Martin;Elizabeth Sinclair;Barry Bredt

  • Relationship between T Cell Activation and CD4+ T Cell Count in HIV-Seropositive Individuals with Undetectable Plasma HIV RNA Levels in the Absence of Therapy

    Peter W. Hunt;Jason Brenchley;Elizabeth Sinclair;Joseph M. McCune

  • Plasma Levels of Bacterial DNA Correlate with Immune Activation and the Magnitude of Immune Restoration in Persons with Antiretroviral-Treated HIV Infection

    Wei Jiang;Michael M. Lederman;Peter Hunt;Scott F. Sieg

  • HIV-infected individuals with low CD4/CD8 ratio despite effective antiretroviral therapy exhibit altered T cell subsets, heightened CD8+ T cell activation, and increased risk of non-AIDS morbidity and mortality.

    Sergio Serrano-Villar;Talia Sainz;Sulggi A. Lee;Peter W. Hunt

  • Progression of atherosclerosis as assessed by carotid intima-media thickness in patients with HIV infection.

    Priscilla Y. Hsue;Joan C. Lo;Arlana Franklin;Ann F. Bolger

  • Tryptophan catabolism by indoleamine 2,3-dioxygenase 1 alters the balance of TH17 to regulatory T cells in HIV disease.

    David Favre;Jeff Mold;Peter W. Hunt;Bittoo Kanwar

  • Risk of Anal Cancer in HIV-Infected and HIV-Uninfected Individuals in North America

    Michael J. Silverberg;Bryan Lau;Amy C. Justice;Amy C. Justice;Eric Engels

  • Gut Epithelial Barrier Dysfunction and Innate Immune Activation Predict Mortality in Treated HIV Infection

    Peter W. Hunt;Elizabeth Sinclair;Benigno Rodriguez;Carey Shive

  • Incomplete Peripheral CD4+ Cell Count Restoration in HIV-Infected Patients Receiving Long-Term Antiretroviral Treatment

    Colleen F. Kelley;Christina M. R. Kitchen;Peter W. Hunt;Benigno Rodriguez

  • Role of viral replication, antiretroviral therapy, and immunodeficiency in HIV-associated atherosclerosis.

    Priscilla Y Hsue;Peter W Hunt;Amanda Schnell;S Craig Kalapus

  • Altered Virome and Bacterial Microbiome in Human Immunodeficiency Virus-Associated Acquired Immunodeficiency Syndrome

    Cynthia L. Monaco;David B. Gootenberg;Guoyan Zhao;Scott A. Handley

  • Decline in HIV infectivity following the introduction of highly active antiretroviral therapy.

    Travis C Porco;Jeffrey N Martin;Kimberly A Page-Shafer;Amber Cheng

  • Predictive value of plasma HIV RNA level on rate of CD4 T-cell decline in untreated HIV infection.

    Benigno Rodríguez;Ajay K. Sethi;Vinay K. Cheruvu;Wilma Mackay

  • Suberoylanilide Hydroxamic Acid Reactivates HIV From Latently Infected Cells

    Xavier Contreras;Marc Schweneker;Ching-Shih Chen;Joseph M. McCune

Frequent Co-Authors

Steven G. Deeks
Steven G. Deeks University of California, San Francisco
Peter W. Hunt
Peter W. Hunt University of California, San Francisco
David R. Bangsberg
David R. Bangsberg Simon Fraser University
Jessica E. Haberer
Jessica E. Haberer Harvard University
Joseph M. McCune
Joseph M. McCune University of California, San Francisco
Frederick Hecht
Frederick Hecht University of California, San Francisco
Alexander C. Tsai
Alexander C. Tsai Harvard University
Elizabeth Sinclair
Elizabeth Sinclair University of California, San Francisco
Mari M. Kitahata
Mari M. Kitahata University of Washington
Richard D. Moore
Richard D. Moore Johns Hopkins University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Immunology in the USA opens doors to a variety of online degree options and promising career paths. For those interested in healthcare roles closely linked to immunology, nursing programs offer a flexible route. The online RN programs for non nurses in Florida are an excellent choice for individuals switching careers or starting fresh in nursing.

Accelerated learning options can help fast-track your nursing credentials. The easiest accelerated nursing programs provide accessible pathways for professionals looking to advance quickly without sacrificing quality education.

For those interested in foundational nursing roles that can complement immunology knowledge, exploring the lpn programs easy to get into offers a practical entry point into patient care, often with shorter completion times and more flexible admission standards.

Advancing further into specialized practice, nurse practitioner degrees merge clinical expertise with leadership skills. Identifying which nurse practitioner program is easiest to enter can be crucial for career advancement, particularly for those interested in immunology-related patient care and research roles.

Best Scientists Citing Jeffrey N. Martin

Trending Scientists